Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
8,92 USD | -0,11% | -15,61% | +12,06% |
Attività
Numero di dipendenti: 76
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United Kingdom
100,0
%
| 0 | nan % | 7 | 100,0 % | - |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Saurabh Saha
CEO | Chief Executive Officer | 47 | 01/01/21 |
Director of Finance/CFO | 53 | 01/03/21 | |
Ellie Im
CTO | Chief Tech/Sci/R&D Officer | - | 03/10/23 |
April Dovholuk
COO | Chief Operating Officer | - | 03/10/23 |
David Chao
ADM | Chief Administrative Officer | 56 | 01/04/21 |
Investor Relations Contact | - | 01/06/22 | |
Harris Rotman
LAW | General Counsel | - | 01/07/22 |
Patrick Yue
PRN | Corporate Officer/Principal | - | 01/03/23 |
Iqbal Hussain
LAW | General Counsel | 43 | 01/02/21 |
Karen Anderson
HRO | Human Resources Officer | 57 | 30/11/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 61 | 23/02/21 | |
Chairman | 54 | 01/11/20 | |
Brett Zbar
BRD | Director/Board Member | 51 | 01/01/21 |
Saurabh Saha
CEO | Chief Executive Officer | 47 | 01/01/21 |
Samarth Kulkarni
BRD | Director/Board Member | 45 | 23/02/21 |
Arjun Goyal
BRD | Director/Board Member | - | 01/01/21 |
Carol Stuckley
BRD | Director/Board Member | 68 | 17/05/21 |
Director/Board Member | 70 | 01/07/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 100 305 850 | 88 670 371 ( 88,40 %) | 0 | 88,40 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+12,06% | 991 Mln | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione CNTA
- Società Centessa Pharmaceuticals plc